Lv7
4990 积分 2023-01-03 加入
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2天前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
18天前
已完结
Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
18天前
已完结
Facile discovery of surrogate cytokine agonists
18天前
已完结
Understanding the tumor immune microenvironment (TIME) for effective therapy
1个月前
已完结
More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade
1个月前
已完结
Interleukin 2-Based Cancer Immunotherapies: The Discovery of Next-Generation Antibody-Cytokine Bispecific Antibody Drug
2个月前
已完结
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
2个月前
已完结
Rationally Designed Less Toxic SPD‐304 Analogs and Preliminary Evaluation of Their TNF Inhibitory Effects
3个月前
已完结
Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
3个月前
已完结
皖公网安备34019202002308
